In this paper, we introduce a new radiomic descriptor, Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe) for capturing subtle differences between benign and pathologic phenotypes which may be visually indistinguishable on routine anatomic imaging. CoLlAGe seeks to capture and exploit local anisotropic differences in voxel-level gradient orientations to distinguish similar appearing phenotypes. CoLlAGe involves assigning every image voxel an entropy value associated with the co-occurrence matrix of gradient orientations computed around every voxel. The hypothesis behind CoLlAGe is that benign and pathologic phenotypes even though they may appear similar on anatomic imaging, will differ in their local entropy patterns, in turn reflecting subtle local differences in tissue microarchitecture. We demonstrate CoLlAGe's utility in three clinically challenging classification problems: distinguishing (1) radiation necrosis, a benign yet confounding effect of radiation treatment, from recurrent tumors on T1-w MRI in 42 brain tumor patients, (2) different molecular sub-types of breast cancer on DCE-MRI in 65 studies and (3) non-small cell lung cancer (adenocarcinomas) from benign fungal infection (granulomas) on 120 non-contrast CT studies. For each of these classification problems, CoLlAGE in conjunction with a random forest classifier outperformed state of the art radiomic descriptors (Haralick, Gabor, Histogram of Gradient Orientations).
Scientific RepoRts | 6:37241 | DOI: 10.1038/srep37241 orientation (λ) parameters. Gabor features can be extracted as a response to convolution of an image with distinct Gabor filters obtained by varying each of the associated parameters (t, λ) across the filter bank. However, Gabor filters capture a global response for an image at a specific value of (t, λ), and may not capture local variations in orientations on a per-pixel basis within local neighborhoods, which may be an important attribute when computing differences across similar-appearing micro-textures. Other popular radiomic features include histogram of gradient orientations (HOG) 11 . HOG yields a global patch-based signature by computing histogram distribution of orientations obtained from computing differences in image intensities in X and Y directions on a per pixel basis. A variant of HOG, called co-occurrence of histogram of gradient orientations (Co-HOG) was recently presented by Watanabe et al. 12 and Pang et al. 13 for pedestrian detection. Co-HOG is a multiple-gradient-orientation-based feature descriptor. Its computation yields a high dimensional feature vector that combines neighbor gradient orientations to quantify shape-based appearances in regions of interest. However, the Co-HOG approach in refs 12-14 (a) does not capture localized intensity-dependent variations across neighboring orientations, and (b) is susceptible to "curse of dimensionality" (due to a high dimensional feature space). Recently, Lee et al. 15 developed a novel quantitative feature called cell orientation entropy (CoRE) to capture differences in orientation of nuclei with respect to the neighboring nuclei across different pathologies, and demonstrated differences in nuclear orientations across aggressive and benign conditions in the context of prostate cancer. If such pathologic differences are indeed reflected at the radiologic level (even though these differences may not be visually discernible), it begs the question whether a radiomic descriptor could be developed to capture the histologic anisotropy across different pathologies at the radiologic scale.
In this work, we present a new radiomic descriptor, Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe), to capture anisotropic tensor gradient differences across similar appearing pathologies in an image. The rationale behind CoLlAGe, is that even though overall the global textural patterns or even the filter responses at a majority of pixel locations might be similar between two differing pathological conditions (e.g. RN versus rBT, FA versus TN breast cancer or adenocarcinomas versus granulomas), the organization and co-occurrences of local tensor gradients may differ across classes and will be relatively consistent within a class. CoLlAGe seeks to capture these local anisotropic differences in micro-structures by measuring entropy (a mathematical construct to measure disorder) of co-occurrences of pixel/voxel-level gradient orientations computed within a local neighborhood. The rationale being that the distribution of entropy of localized gradient field within a lesion will be high for aggressive disease conditions, potentially manifesting their inherent disorder and high heterogeneity appreciable at a cellular scale, as compared to benign pathologies which have a more coherent micro-architecture. An example of CoLlAGe is shown in Fig. 1(e) and (i) to distinguish two synthetic checkerboard images with similar-appearing patterns. CoLlAGe was found to capture localized variations in gradients on a per-pixel basis (reflected by high CoLlAGe values) across the two patterns, differences that were not appreciable on Haralick and Gabor feature representations.
The rest of the paper is organized as follows. The algorithm of CoLlAGe is detailed in the Methodology section, followed by the experimental setup to demonstrate the utility of CoLlAGe in the context of three problems involving brain tumors, breast cancer, and lung cancer. Subsequently we present and discuss the results followed by the concluding remarks.
Methodology of CoLlAGe
In the following subsections, we describe the detailed mathematical formulation of our CoLlAGe strategy, both in 2-dimensions (2D) and in 3-dimensions (3D). A preliminary implementation of 2D CoLlAGe was previously presented in ref. 16 . Figure 2 shows the workflow of CoLlAGe in 2D, while the 3D implementation is shown in Fig. 3 . Notation. An MRI image scene  is defined as
) is associated with an intensity value f(c). A local neighborhood of  pixels/voxels is defined within a window W, while the co-occurrence matrix computed from within W is denoted as . The entropy map is given as , and the final CoLlAGe feature vector is denoted as F. For the sake of clarity, the notations used for computation of 2D CoLlAGe are denoted with superscript 2D, while the notations for computation of 3D CoLlAGe are denoted with superscript 3D. The common notations, operators and acronyms employed in this paper are listed in Table 1 . × window W centered around every c ∈ C is selected to compute the localized gradient field. We then compute ∂ f X (c k ) and
 . The vector gradient matrix  associated with every c is given by is computed by aggregating
}, where |·| is the cardinality of set , do 
Co-occurrence matrix computed from θ
Entropy map computed from
Co-occurrence matrix computed from φ
Entropy map computed from  
Compute gradient vectors in neighborhood, i ∈ (x, y, z),
Obtain localized gradient vector
Compute dominant components ψ(c k11 ), ψ(c k12 ), and ψ(c k13 ), , by SVD of ;
Obtain dominant directions θ(c k ) and φ(c k ), using Equations 3 and 4 respectively;
end
Compute co-occurrence matrix  from θ(c k ) and  ∼ from φ(c k ) using Equation 1; given as: 
Two co-occurrence matrices 
Experimental Design
Datasets and Preprocessing. In this work, we employed three unique dataset cohorts obtained from different collaborating institutions to evaluate the efficacy of CoLlAGe on three extremely challenging clinical problems: (a) distinguishing radiation necrosis, a relatively benign effect of radiation, from tumor recurrence on T1-w MRI in brain tumors, (b) distinguishing different molecular sub-types of breast cancer on DCE-MRI, and (c) distinguishing adenocarcinomas from granulomas on non-contrast CT images. Details regarding inclusion criteria, pre-processing, and experimental design for each of the three datasets are provided below.
Brain tumor dataset. Imaging scans were acquired under an Institutional Review Board (IRB)-approved (IRB # CC00148) and HIPAA-compliant study at University Hospitals, Cleveland (UH). The patient cohorts were identified by performing a retrospective review of neuropathology in all brain tumor patients who underwent a surgery of a recurrent or progressive Gd T1w-enhancing lesion identified during follow-up post-9 months (or later) after the initial after brain radiation therapy. Follow-up MRI scans within 0-21 days prior to second resection or biopsy (for disease confirmation) were used for analysis. Written informed consent was obtained from all the subjects. Inclusion criteria were that the pathology specimen must have been obtained by resection (preferably) or by multiple biopsies (> 2) via stereotactic guidance. Fewer than two biopsies were not allowed because of the potential for sampling error. Histology was re-reviewed by a neuropathologist, blinded to the original diagnosis and type of radiation, in order to quantify the percentage of radiation necrosis and recurrent tumor. In order to avoid any training errors due to "mixed" pathologies on the same lesion the presence of RN was strictly defined as > 80% RN and of recurrent tumor as > 80% recurrent tumor (other "mixed" cases with varying proportions of RN and tumor recurrence were excluded). We identified a total of 42 cases, from 2006 to 2014 that followed this strict inclusion criterion. Table 2 .
Breast cancer dataset. Breast MRI data was prospectively collected in an Institutional Review Board-approved (IRB #02-13-42C), HIPAA-compliant study at the University of Pennsylvania (UPenn) between 2002 and 2007. Written informed consent was obtained from all subjects. Women without contraindication to MRI or gadolinium who presented with either a suspicious breast lesion or known malignancy prior to surgery were recruited to a larger single-institution study of MRI in the staging, diagnosis, and screening of breast cancer. Women who underwent neoadjuvant chemotherapy prior to surgery were excluded, as were women who had excisional biopsy prior to entry. From this data set we sub-selected women whose pathology revealed invasive cancer. Subjects whose images of the index lesion demonstrated substantial metallic artifact from prior biopsy were also excluded. This study examined MRI characteristics in 76 solid lesions from 65 patients for whom pathology results and, where applicable, ER, PR, and HER2 results were available. Reference standard diagnosis was made by histopathologic examination of tissue obtained by either core biopsy sampling or lumpectomy. Of the 76 lesions, 12 were benign fibroadenomas and 64 were invasive carcinomas. All of the carcinomas were immunohistochemically stained for hormone receptors and HER-2/neu. In cases in which staining for HER-2/neu was inconclusive, amplification was confirmed with fluorescence in situ hybridization. Table 3 .
Lung cancer dataset. Two separate datasets of non-contrast Lung CT scans were prospectively collected in an Institutional Review Board-approved (IRB #02-13-42C), HIPAA-compliant study from two collaborating institutions: University Hospitals, Cleveland and Cleveland Clinic Foundation (CCF) in 2013 and 2014. Written informed consent was obtained for all the studies within the two cohorts. Histology was confirmed by anatomical pathologists at the respective institutions from the surgical specimen available for studies employed in both the cohorts. All patients underwent non-contrast CT scans prior to resection as part of routine care. Patients with multiple solitary nodules were excluded. Dataset 1 from University Hospitals, used as the training set, comprised 64 studies (31 adenocarcinomas and 33 granulomas). Dataset 2, from Cleveland Clinic, consisted of 56 cases (34 adenocarcinomas and 22 granulomas), and was used as an independent test set. The CTs were acquired using Siemens scanners with 2 mm slice thickness and 1 mm reconstruction. The tube voltage/current was 120 kV/150 mAs. The clinicopathologic characteristics of the lung cancer dataset have been summarized in Table 4 . Pre-processing. For the brain tumor cohort, the lesion ROIs were manually traced by an expert neuroradiologist, with over 25 years of experience, using the annotation tool in 3D Slicer after skull-stripping and intensity standardization. Intensity standardization 17, 18 is an essential pre-requisite when comparing image intensities across different acquisitions, as it allows the gray scale MR intensities to have a fixed tissue-specific meaning within the same imaging protocol and the same body region, and within the same patient. For the brain MRI cohort, the segmented regions included enhancing and non-enhancing neoplastic tissue with the exclusion of edema. The neuroradiologist annotated all the 2D slices that had visible lesions.
Primary Brain tumors Metastatic Brain Tumors
For the breast cancer and lung cancer cohort, the best representative section, which was a central section of either the DCE-MRI volume or the non-contrast CT scan, was annotated by a breast radiologist and a thoracic radiologist respectively, who were both blinded to the pathologic diagnosis. Both for lung and breast cohorts, the lesion boundary was manually delineated on the basis of the image that demonstrated the greatest lesion conspicuity from neighboring tissues, which was then used for subsequent analysis.
Comparison of CoLlAGe with other popular texture features. While we qualitatively evaluated 3D
CoLlAGe on a limited cohort of studies, quantitative analysis for all the three use cases in brain, breast, and lung, was restricted to 2D CoLlAGe, due to the variable slice thickness and anistropic MRI volumes of our retrospective studies. We compared the performance of 2D CoLlAGe with other state-of-the-art texture descriptors (i.e. Haralick, Gabor, HOG). Apart from CoLlAGe, we extracted a total of 584 2D texture features for the ROIs on a per-pixel basis, including 52 Haralick features, 432 Gabor features and 100 HOG descriptors. The Gabor filter bank consisted of six different frequency-shift values ∈ … t {0, 2, 4, , 32}, eight orientation parameter values λ ∈ . … {0, 22 5, 45, , 180}, and 9 different variance settings, generating a total of 432 different filters. Each filter yielded a real and imaginary response, which were used to calculate the total response magnitude for every region of interest. HOG features were computed via pixel-wise gradient orientations obtained from the grayscale intensity differences in the region of interest. These orientations were then equally binned into v bins, ∈ v {10, 15, 20, 25, 30}, with each bin encompassing 36°, 24°, 18°, 14.4° or 12°. For Haralick and Gabor descriptors, the feature representations were obtained from every lesion by computing the median of feature values across all pixels within a lesion. Summary of parameters used for different feature sets is provided in Table 5 .
Comparison of CoLlAGe with expert diagnosis. To further demonstrate the efficacy of CoLlAGe in dis-
tinguishing similar appearing pathologies on imaging, we performed a human machine comparison for our brain (N = 42) and lung (N = 20) cohort. For both the cohorts, collaborating expert readers (board certified attending radiologists and pulmonologists) independently provided a diagnosis, which was then compared with the analysis from the CoLlAGe classifier. In both the human-machine comparison experiments, the expert readers were kept blinded to the pathology reports. The experts assigned a score between [0, 1] to each lesion, with 0 referring to a high confidence that the nodule is "benign" (radiation necrosis or granuloma), and 1 being "malignant" (recurrent tumor or adenocarcinoma). Similarly, probability scores were assigned by the Random Forest classifier using CoLlAGe features. Using the assigned probabilities we computed the areas under the respective receiver operating characteristic curves (AUCs).
Experimental Evaluation. The feature sets were used to train a Random Forest (RF) classifier 19 , a boostrapped aggregation of multiple decision tree classifiers, in conjunction with F 2D to distinguish between the categories of interest. Wilcoxon's rank sum test 20 was employed to assess statistical significance and corrected for multiple comparisons for the experiments performed for the three use-cases. The sample size for the different experiments has been summarized in Table 6 . In all our experiments, the RF classifier was used to assign every ROI into classes {+ 1, − 1} based on the following classification tasks:
• Experiment 1: Distinguishing radiation necrosis from recurrent tumor on MRI, • Experiment 2: Distinguishing triple negatives from other molecular subtypes of breast cancer (ER+ , HER2+
and benign FA) on MRI, • Experiment 3: Distinguishing adenocarcinoma from granuloma on non-contrast CT.
Experiment E 1 : Distinguishing Radiation Necrosis from Recurrent Tumor. We computed F
2D for every slice with expert-annotated ROI on the primary and metastatic brain tumor cohorts and employed the feature set in a RF classifier setting to distinguish RN from rBT such that slices from the same patient are either used for training or for testing. A total of 50 trees were used for training the RF classifier. 3-fold randomized cross-validation was used to train and evaluate classifier performance. This involved randomly splitting the entire dataset into 3 equally sized sets with 2 subsets used for classifier training and 1 subset used for independent evaluation. The diagnostic performance of each classifier trained with CoLlAGe and other comparative features was evaluated using average classification accuracy β Acc , computed over 150 iterations of cross-validation runs. Quantitative results across CoLlAGe and the other texture features were compared by computing β Acc for every feature set at the operating point. Additionally, for a subset of studies we computed F 3D for qualitative visualization. Qualitative results for both 2D and 3D CoLlAGe feature representation were visualized as standard heatmaps where high CoLlAGe values were shown in red while blue represented low CoLlAGe values.
Experiment E 2 : Distinguishing Molecular Subtypes of Breast Cancer. F
2D was similarly computed for the slices with expert annotated ROI for the breast cancer cohort and was used to distinguish triple negative from the other breast cancer subtypes (ER+ , HER2+ ) and benign fibroadenoma. A similar cross-validation technique was employed, along with a comprehensive comparison with other texture descriptors as given in E 1 .
Experiment E 3 : Distinguishing Adenocarcinomas from Granulomas. For every slice with the expert annotated ROI, F
2D was similarly computed for the lung cancer cohort and was used to distinguish adenocarcinomas from granulomas. Cross-validation, along with a comprehensive comparison with other texture descriptors as given in E 1 was employed for the training set. This cross-validation strategy was employed for all the parameters as listed in Table 5 . The model using the parameters that yielded the best results, for each category of feature descriptors, across the aggregated cross-validation runs was 'locked down' , and then used to classify the cases in the independent test cohort.
Parameter Sensitivity Analysis. The sensitivity of CoLlAGe features was evaluated across its two key parameters, bin size of the entropy histogram (v) and neighborhood ( )  size for computing localized orientations. To account for smaller lesion sizes across the two cohorts, we restricted the  ∈ … {3, 5, , 11}. Bin sizes ∈ … v {10, 15 , 30} were additionally considered at regular bin intervals of 5 to evaluate variation in β Acc . We reported the variation in β Acc as a function of  and v. v > 20, and  = 9 (Fig. 4) were found to be optimal parameters for the brain tumor cohort. Similarly, for the breast cancer cohorts (results not shown), the following pairs of parameters were found to be optimal: v = 30, and  = 5 for TN versus ER+ , v = 30, and = 11  both for TN versus HER2+ and TN versus FA. For the lung cancer cohort, the best parameters were found to be v = 10, and = 3  . The bounds of the different parameters were selected in a way that accounted for boundary effects that would arise in case of relatively small lesions
, and when v > 30. Figure 4 shows the parameter sensitivity for all the different classification experiments using CoLlAGe.
Results and Discussion
Experiment E 1 : Distinguishing Radiation Necrosis from Recurrent tumor. Figure 5 shows the qualitative feature maps of 3D CoLlAGe on a Gd-T1 MRI for radiation necrosis (a) and recurrent tumor (e) respectively. The localized gradient field, θ 3D , for radiation necrosis and recurrent tumor is shown in (b) and (e), while the CoLlAGe entropy heatmaps, The quantitative results including comparison of the classification performance of 2D CoLlAGe with Haralick, Gabor, and HOG, using the best parameter settings, are shown in Table 7 . The best classification accuracy obtained for the popular-texture features was reported to be between 50% to 65%, while CoLlAGe was found to perform significantly better (over 20% improvement in classification accuracy (p-value < 0.001)) with an accuracy of 83.79 ± 5.43% for primary cases, and 88.52% ± 3.93 for the metastatic brain tumor cohort. It has been previously shown that anomalies in brain tissue morphology are associated with directional patterns that can be captured by texture analysis. For example, gyrifications in gray matter create oriented spatial frequencies, that can be captured by wavelet-based features. Kovalev et al. 21 have analyzed gradient and anisotropy properties of 3D texture in the context of neurodegenerative diseases. According to Georgiadia et al. 22 , brain lesion texture is correlated with presence and type of cancer cells. A recent study 23 employed Haralick and wavelet texture features to distinguish radiation necrosis from metastatic brain tumor recurrence with a reported AUC of 94%. However, we believe that the results, reported on a per-slice basis, may have been affected by the classifier being contaminated by slices from the same patient being used both within the training as well as testing sets during classification. It is worth noting that the diagnostic accuracy of distinguishing radiation necrosis from tumor recurrence by an expert radiologist on visual inspection of MRI has been reported to be between 50-60% 24 . Table 7 . β Acc for 2D CoLlAGe and the comparative strategies (Haralick, Gabor, and HOG) obtained across 150 iterations of 3-fold cross validation in a random forest classifier setting for the brain and breast cancer use-cases, as well as for independent training and test dataset for the lung cancer use-case. ) for TN, HER2+ , ER+ and FA are shown in Fig. 6 (e), (f), (g) and (h) respectively. It is interesting to note that the gradient field was found to be more disordered across cancer sub-types, as compared to benign FA. Similar to Experiment E 1 , a marked difference in CoLlAGe values was observed across different sub-types of breast cancer (TN, HER2+ , ER+ , and FA), suggesting that CoLlAGe may potentially be capturing local anisotropic differences in micro-structures on imaging that are otherwise not visually appreciable. 25 that used a similar cohort of breast DCE-MRI studies to distinguish different sub-types of breast cancer using a novel texture kinetic approach. Similar to Agner et al., the most prominent difference, both in qualitative and quantitative performance of CoLlAGe, is reported between FA, a benign condition, from TN, the most aggressive sub-type of breast cancer with β Acc of 90.06 ± 4.38. It is worth noting that currently radiologists are unable to distinguish TNs from FAs on a routine MRI [26] [27] [28] . Experiment E 3 : Distinguishing Adenocarcinomas from Granulomas. Figure 7 shows the qualitative 2D CoLlAGe feature maps for a representative non-contrast CT image with pathologically proven adenocarcinoma (a) and granuloma (d), respectively. Higher CoLlAGe values are reflected in red, while blue reflects low CoLlAGe values. It may be observed that representative adenocarcinoma lesion has higher density of larger CoLlAGe entropy values as compared to the granuloma sample. Table 7 shows the average β Acc values obtained over 150 iterations of a 3 fold-cross validation via a RF classifier. Using the locked-down classifier, CoLlAGe features showed the best classification results for the test set (69.8%).
Tumor heterogeneity has been previously shown to be associated with non-small cell lung carcinoma 29 . This heterogeneity can be attributed to the hypoxic microenvironment 30 . The subtle differences in the hypoxia-related heterogeneity as suggested in ref. 29 is perhaps manifested in the differential expression of CoLlAGe entropy. Dennie et al. 31 have reported an AUC of 0.90 in distinguishing the two conditions. The texture analysis in ref. 31 , using Haralick features, has yielded higher accuracy than FDG-PET/CT in distinguishing the two pathologies. However, the approach in ref. 31 has not been validated on an independent test set. Besides, there is no clear qualitative evidence of the Haralick features visibly distinguishing the two pathologies.
Human-Machine Comparison Results.
On the hold-out lung cohort, the AUCs for the two experts were found to be 0.68, and 0.54 respectively. Using the CoLlAGe features, the associated AUC was computed as 0.78. For the brain tumor studies, AUCs for the two independent readers were 0.75 and 0.58 respectively, while the same for a CoLlAGe-based classifier was computed to be 0.80. To the best of our knowledge, no radiomics-based work recently has demonstrated such a rigorous and comprehensive human-machine reader comparison across multiple disease sites.
Concluding Remarks
We presented a radiomic feature descriptor, Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe), that captures higher order co-occurrence patterns of local gradient tensors at a voxel level to distinguish disease phenotypes that have similar morphologic appearances. We employed three clinically challenging datasets to evaluate the efficacy of CoLlAGe, distinguishing (a) radiation necrosis, a relatively benign effect of radiation, from tumor recurrence on T1-w MRI in brain tumors, (b) different molecular sub-types of breast cancer on DCE-MRI and (c) adenocarcinomas from granulomas on non-contrast CT. Additionally, we compared performance of CoLlAGe with other state-of-the-art texture descriptors (Haralick, Gabor, Histogram of Gradient orientations) as well as across two expert readers (for two use-cases), and demonstrated that CoLlAGe has significantly better classification accuracy than the other texture descriptors as well as the expert readers. Across the cross-validation and testing stages, CoLlAGe outperformed other texture features in 20 out of 21 comparative experiments (Table 7) . Our results, on all three cohorts, seem to suggest that CoLlAGe has the potential to serve as a powerful radiomic descriptor in distinguishing similar appearing pathologies on imaging.
Nevertheless, there are a few limitations to our study. Firstly, CoLlAGe was only compared against three popularly used texture features (Haralick, Gabor, and HOG). Secondly, based on our parameter sensitivity analysis, it appears that parameter selection may be an important consideration when employing CoLlAGe for a specific problem. In this paper, histogram representation was used to collate CoLlAGe values to classify every image within a random forest classifier. However, the choice of feature representation and classification methods is flexible and can be modified depending on the specific application. Future work will focus on (1) rigorously evaluating efficacy of CoLlAGe across other texture features on a larger cohort of multi-institutional studies, and (2) identifying a domain-independent parameter selection strategy to evaluate robustness of CoLlAGe.
